Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Open-label, Randomized, Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

NCT06597201 is registered in ClinicalTrials.gov with Chengdu Qingshan Likang Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06597201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06597201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Open-label, Randomized, Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
Lead sponsor
Chengdu Qingshan Likang Pharmaceutical Co., Ltd
Phase
Phase 4
Overall status
Recruiting
Start date
August 9, 2024
Completion date
June 29, 2025
Enrollment
400 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease (esrd)